- Association of STAT3 with Cx26 and Cx43 in human uterine endometrioid adenocarcinoma
URSZULA SULKOWSKA et al, 2016, Oncology Letters CrossRef - STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence
Benjamin L. Bryson et al, 2017, Cell Cycle CrossRef - Cancer Stem Cell Plasticity Drives Therapeutic Resistance
Mary Doherty et al, 2016, Cancers CrossRef - Effects of BPA on global DNA methylation and global histone 3 lysine modifications in SH-SY5Y cells: An epigenetic mechanism linking the regulation of chromatin modifiying genes
Mine Senyildiz et al, 2017, Toxicology in Vitro CrossRef - Human Intervention Study to Assess the Effects of Supplementation with Olive Leaf Extract on Peripheral Blood Mononuclear Cell Gene Expression
Anna Boss et al, 2016, International Journal of Molecular Sciences CrossRef - MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3
Dan Shan et al, 2019, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef - Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer
Alessandra Caligiuri et al, 2022, Cancers CrossRef - Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer
Giulia Bottai et al, 2017, International Journal of Molecular Sciences CrossRef - High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer
John J. Wallbillich et al, 2017, PLOS ONE CrossRef - Prostaglandin E2 triggers cytochrome P450 17α hydroxylase overexpression via signal transducer and activator of transcription�3 phosphorylation and promotes invasion in endometrial cancer
Jieqi Ke et al, 2018, Oncology Letters CrossRef - The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma
Qianhui Li et al, 2018, Biomedicine & Pharmacotherapy CrossRef - Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer
Jieqi Ke et al, 2016, Tumor Biology CrossRef - Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression
Marie Simonneau et al, 2018, Oncotarget CrossRef - Ulipristal acetate simultaneously provokes antiproliferative and proinflammatory responses in endometrial cancer cells
Ranka Kanda et al, 2022, Heliyon CrossRef - Using Supervised Learning Methods for Gene Selection in RNA-Seq Case-Control Studies
Stephane Wenric et al, 2018, Frontiers in Genetics CrossRef - Oncostatin M Reduces Pathological Neovascularization in the Retina Through Müller Cell Activation
Julian Rapp et al, 2024, Investigative Opthalmology & Visual Science CrossRef - Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer
Jacob M. Smigiel et al, 2017, Molecular Cancer Research CrossRef - EXPOsOMICs: Meet-in-the-Middle and Network Perturbation
Christiana A. Demetriou et al, 2019, Unraveling the Exposome CrossRef - Expression of Oncostatin M in Early Gastric Cancer and Precancerous Lesions
Jihua Shi et al, 2019, Gastroenterology Research and Practice CrossRef - Oncostatin M is a novel biomarker for coronary artery disease – A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus
Shohei Ikeda et al, 2021, IJC Heart & Vasculature CrossRef - Adipocytokines and disease progression in endometrial cancer: a systematic review
Irene Ray et al, 2022, Cancer and Metastasis Reviews CrossRef - Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis
Giovanni Di Maira et al, 2022, The Journal of Pathology CrossRef - Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
D J Junk et al, 2017, Oncogene CrossRef - Oncostatin M: A mysterious cytokine in cancers
Ali Masjedi et al, 2021, International Immunopharmacology CrossRef